About The HRT Index

The HRT Index is an independent editorial publication covering online hormone therapy options for women in perimenopause and menopause. We help readers compare provider models, pricing, hormone options, safety considerations, insurance and payment structures, follow-up policies, and clinical-review depth.

The HRT Index is published by The HRT Index LLC, a Delaware company. Our editorial work is separate from commercial relationships. We do not accept payment for inclusion, ranking, awards, or favorable editorial copy. We publish our methodology, editorial standards, and medical review policy.

Why this publication exists

Menopause care is often difficult for patients to navigate. Training, comfort, and access vary widely across primary care, OB/GYN, and telehealth settings. That does not mean every in-person clinician is unprepared, and it does not mean every online service is high quality. Our role is to help readers understand the trade-offs, questions to ask, and provider differences before they speak with a licensed clinician.

The 2002 Women's Health Initiative communication created lasting confusion about HRT risks and benefits. The major menopause societies have since substantially revised their positions — the evidence supports a more individualized, benefit-risk framing — but the clinical and public conversation has been slow to follow. This publication exists to close that information gap, honestly.

Who we are

The HRT Index is produced by named editors, researchers, and writers listed on our Editorial Team page. When a page is clinically reviewed, the named clinician reviewer and review date appear at the top of that page. Pages without clinical review are labeled “Editorial research — not medically reviewed.”

We do not provide medical care, prescribe medications, order labs, diagnose conditions, or create clinician-patient relationships.

What we cover

The initial publication scope is online HRT providers serving women in the United States. The roadmap includes provider-specific reviews of the larger services in the category, deeper coverage of specific conditions in the perimenopause-to-postmenopause arc (vasomotor symptoms, sleep, mood, bone, cardiometabolic health, genitourinary syndrome of menopause), and adjacent women's-midlife topics where there is a real reader need and where we can hold ourselves to the same editorial standard.

What we are not

The HRT Index is not a telehealth provider, pharmacy, medical practice, insurance broker, or emergency service. We do not decide whether HRT is appropriate for any individual reader. Any decision to start, stop, or change hormone therapy should be made with a licensed clinician who knows the reader's medical history. If you are experiencing a medical emergency, call emergency services.

We do not cover men's testosterone replacement. We do not cover fertility, contraception, or pregnancy. Reach us at our contact page.